GVD is a chemotherapy regimen, used for salvage treatment of relapsed or refractory Hodgkin disease, including those patients who relapse after stem cell transplantation.[1]

The GVD regimen consists of three drugs, from which its name is derived:

  1. Gemcitabine;
  2. Vinorelbine; and
  3. Doxil, a pegylated liposomal formulation of doxorubicin.

Dosing

edit
Drug Dose in transplant-naive patients Dose in post-transplant patients Mode Days
Gemcitabine 1000 mg/m2 800 mg/m2 IV infusion Days 1, 8
Vinorelbine 20 mg/m2 15 mg/m2 IV bolus Days 1, 8
Doxil 15 mg/m2 10 mg/m2 IV infusion Days 1, 8

Repeated every 21 days (3 weeks).

References

edit